A Self-replicating COVID-19 mRNA Vaccine

Sailender19 May, 2022Health

A third messenger RNA (mRNA) vaccine appears to have proved its worth against COVID-19. This novel mRNA vaccine may come with significant advantages such as easier storage, along with lower cost because its ?self-amplifying? design allows for smaller doses. Arcturus Therapeutics, which staged a placebo-controlled trial of its candidate in more than 17,000 participants that the vaccine had 55% efficacy against symptomatic COVID-19 and provided 95% efficacy against severe illness and death.